At Pharmidex, we help drug developers hit their IND submission dates with high-quality, efficient solutions
September 1, 2025
- Designing robust preclinical studies that deliver accurate data the first time.
- Building flexibility into plans to prevent delays when priorities shift.
- Coordinating ADME, PK/PD, and toxicology in parallel to save weeks.
With over 16,000 projects conducted successfully, work with a proven partner from early discovery to regulatory submission.
Our tailored, quality-driven approach keeps your programme on track and your milestones within reach.
Let’s make your IND deadline a milestone you hit with confidence
Head of Respiratory at Pharmidex , Ian Knowles will be attending the Drug Delivery to the Lungs Conference (DDL) on 10–12 December 2025 at the Edinburgh International Conference Centre. DDL brings together global leaders in pulmonary and respiratory drug delivery, and Ian looks forward to meeting fellow attendees, exploring collaborations, and discussing how Pharmidex can support and accelerate drug discovery and development across industry and academia. If you’ll be there too, feel free to reach out we look forward to building new connections and advancing innovation together.
Pharmidex is pleased to announce that Dr. Mo Alavijeh (FRSC, FRSM) and Janette Dalay Robertson will attend the “Recent Clinical Candidates and SMR Award Meeting” this Thursday, 4 December 2025. If you’re attending, we’d be happy to connect!
Pharmidex is pleased to announce that Dr. Mo Alavijeh (FRSC, FRSM) , and our Dr. Ian Knowles , will attend Genesis 2025 this Wednesday, December 3rd, hosted by One Nucleus . They look forward to meeting fellow attendees, exploring new collaborations, and building partnerships with companies and academic groups to advance drug discovery and development. See you at Genesis 2025!
